• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of shield-arms typed oligonucleotides for cancer therapy

Research Project

Project/Area Number 23790202
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Medical pharmacy
Research InstitutionSt. Marianna University School of Medicine

Principal Investigator

FUJIWARA Naruyoshi  聖マリアンナ医科大学, 医学部, 助教 (50365425)

Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords医療薬剤学 / ドラッグデリバリーシステム / ナノドラッグ / 遺伝子製剤 / デコイ型遺伝子 / IRF-1 / デコイ型遺伝子製剤 / リポソーム
Research Abstract

In this study, I showed that the shield-arms type oligonucleotide was able to down-regulate VEGF expression dependent on TGF-〓 in macrophage and induce anti-tumor effect by enhancement of IRF-1 expression in macrophage residing the tumor environment. It is suggested that this oligonucleotide will become new strategy of anti-angiogenesis by suppression of cancer as shields and activation for macrophages asarms.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (6 results)

All 2012 2011

All Journal Article (3 results) (of which Peer Reviewed: 3 results) Presentation (2 results) Patent(Industrial Property Rights) (1 results) (of which Overseas: 1 results)

  • [Journal Article] Establishment of retinal progenitor cell clones by transfection with Pax6 gene of mouse induced pluripotent stem (iPS) cells.2012

    • Author(s)
      Suzuki N, et. al.
    • Journal Title

      Neurochem Res.

      Volume: 37 Pages: 835-45

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Role of SDF1/CXCR4 Interaction in Experimental Hemiplegic Models with Neural Cell Transplantation.2012

    • Author(s)
      Arimitsu N, et. al.
    • Journal Title

      Int J Mol Sci.

      Volume: 13 Pages: 2636-49

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Journal Article] Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.2011

    • Author(s)
      Shimizu J, et. al.
    • Journal Title

      Clin Exp Immunol.

      Volume: 168 Pages: 68-74

    • Related Report
      2011 Research-status Report
    • Peer Reviewed
  • [Presentation] 癌治療を目的としたシールドアームズ型遺伝子製剤の開発2012

    • Author(s)
      藤原成芳
    • Organizer
      日本薬学会第132 年会
    • Place of Presentation
      札幌
    • Year and Date
      2012-03-31
    • Related Report
      2012 Final Research Report
  • [Presentation] Effect of shield-arms typed oligonucleotides on regulation of tumor-associated macrophage function.2012

    • Author(s)
      Fujiwara N, et, al.
    • Organizer
      日本薬学会
    • Place of Presentation
      札幌(北海道大学)
    • Related Report
      2011 Research-status Report
  • [Patent(Industrial Property Rights)] Method of delivering agent into target cell2011

    • Inventor(s)
      HAGA, Makoto; (JP).FUJIWARA, Naruyoshi; (JP).NISHI, Akihiro; (JP).KUBO, Satoru; (JP).KUSHIBIKI, Takanori; (JP)
    • Industrial Property Rights Holder
      HAGA, Makoto [JP/JP]; (JP) (For US Only).FUJIWARA, Naruyoshi [JP/JP]; (JP) (For US Only).NISHI, Akihiro [JP/JP]; (JP) (For US Only).KUBO, Satoru [JP/JP]; (JP) (For US Only).KUSHIBIKI, Takanori[JP/JP]; (JP) (For US Only)
    • Filing Date
      2011
    • Related Report
      2012 Final Research Report
    • Overseas

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi